Diagnosis |
| As the clinical symptoms of enzootic pneumonia are generally non-specific i.e. they could be caused by a number of different diseases of the respiratory tract, it may be necessary to use laboratory testing to confirm the presence of the pathogen. |
The consequences of the disease are usually identifiable on examination of the lungs of affected pigs at slaughter. Consolidation of the apical lobes is typical of mycoplasma infection however this can also be caused by other pathogens (e.g. APP, etc.) and care should be taken before making a diagnosis based on this alone. |
||||||||||||
A simple and cost-effective way to identify whether or not EP is of clinical significance in a herd is to carry out examination of the lungs of a batch of pigs at slaughter. |
Assessment of how many pigs had lung lesions (frequency) and the percentage of pulmonary tissue affected (severity) can provide a clear view as to the economic significance of the disease in the herd. |
| Blood testing for antibodies |
A more precise diagnosis is possible by the use of an ELISA assay or F.A.Test carried out on blood samples and which identifies the presence of the specific M hyo. antibody. Antibodies can be isolated approximately three to four weeks after infection arises although care should be taken since it is not possible to differentiate between vaccine induced antibodies and those arising as a result of naturally occurring infection. |
| Testing to identify the bacteria |
M hyo can be detected very early in the infection process by means of the PCR testing (polymerase chain reaction) of nasal swabs from infected pigs. The presence of any pathogens on the nasal mucosa cannot, however, be automatically equated with the presence of an infection. An infection is only present if the animal develops clinical symptoms (cough, lung lesions) leading to the development of antibodies. Detection of the organism in the nasal passages may not necessarily mean that an infection has been established and disease is present in the herd. Under normal housing conditions the immune system of a healthy animal can deal with individual pathogenic organisms. |
| © 2006 Boehringer Ingelheim Ltd UK. All rights reserved. Company Registration Number: 711858 Access to and use of this website is subject to our Terms of use which users are deemed to accept by accessing this website. Any queries concerning the design of the site please send an email to the webmaster. |